Literature DB >> 8530010

Association of apolipoprotein E but not B with Alzheimer's disease.

S E Poduslo1, D Riggs, J Schwankhaus, A Osborne, F Crawford, M Mullan.   

Abstract

In our studies apolipoprotein E4 (APOE4) is associated with both early- and late-onset Alzheimer's disease. Alzheimer's patients from West Texas were screened for the APOE4 allele, which was found at frequencies of 0.43 and 0.59 in familial late- and early-onset cases. Sporadic cases had lower frequencies, but they still were 2-4 times higher than control spouses. To determine whether the APOE association may be a risk factor for coronary disease as well, we examined two APOB gene restriction sites that have previously been found to be associated with coronary artery disease, especially myocardial infarctions. The APOB alleles were found at similar frequencies in Alzheimer's patients and control spouses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8530010     DOI: 10.1007/bf00197418

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage.

Authors:  M A Pericak-Vance; J L Bebout; P C Gaskell; L H Yamaoka; W Y Hung; M J Alberts; A P Walker; R J Bartlett; C A Haynes; K A Welsh
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

3.  Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease.

Authors:  N B Myant; J Gallagher; M Barbir; G R Thompson; D Wile; S E Humphries
Journal:  Atherosclerosis       Date:  1989-06       Impact factor: 5.162

4.  Apolipoprotein B-gene DNA polymorphisms associated with myocardial infarction.

Authors:  R A Hegele; L S Huang; P N Herbert; C B Blum; J E Buring; C H Hennekens; J L Breslow
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

5.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

6.  Apolipoprotein E and B polymorphisms--longevity factors assessed in nonagenarians.

Authors:  K Kervinen; M J Savolainen; J Salokannel; A Hynninen; J Heikkinen; C Ehnholm; M J Koistinen; Y A Kesäniemi
Journal:  Atherosclerosis       Date:  1994-01       Impact factor: 5.162

7.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

8.  DNA polymorphisms of the gene for apolipoprotein B in patients with peripheral arterial disease.

Authors:  M V Monsalve; R Young; J Jobsis; S A Wiseman; S Dhamu; J T Powell; R M Greenhalgh; S E Humphries
Journal:  Atherosclerosis       Date:  1988-03       Impact factor: 5.162

9.  DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease.

Authors:  J J Genest; J M Ordovas; J R McNamara; A M Robbins; T Meade; S D Cohn; D N Salem; P W Wilson; U Masharani; P M Frossard
Journal:  Atherosclerosis       Date:  1990-05       Impact factor: 5.162

10.  Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

Authors:  M C Chartier-Harlin; M Parfitt; S Legrain; J Pérez-Tur; T Brousseau; A Evans; C Berr; O Vidal; P Roques; V Gourlet
Journal:  Hum Mol Genet       Date:  1994-04       Impact factor: 6.150

View more
  1 in total

1.  The apolipoprotein CI A allele as a risk factor for Alzheimer's disease.

Authors:  S E Poduslo; M Neal; K Herring; J Shelly
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.